Cargando…
Pretreatment Proteinuria Predicts the Prognosis of Patients Receiving Systemic Therapy for Unresectable Hepatocellular Carcinoma
SIMPLE SUMMARY: Proteinuria is a common adverse event of systemic therapy for hepatocellular carcinoma (HCC); however, its effect on clinical outcomes is not well understood. A retrospective analysis of 321 patients with unresectable HCC who received systemic therapy as first-line treatment was perf...
Autores principales: | Mizuno, Kazuyuki, Imai, Norihiro, Yamamoto, Takafumi, Yokoyama, Shinya, Yamamoto, Kenta, Ito, Takanori, Ishizu, Yoji, Honda, Takashi, Kuzuya, Teiji, Ishigami, Masatoshi, Kawashima, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216745/ https://www.ncbi.nlm.nih.gov/pubmed/37345189 http://dx.doi.org/10.3390/cancers15102853 |
Ejemplares similares
-
Differences in the Intestinal Microbiome Associated with Diarrhea during Lenvatinib Treatment for Hepatocellular Carcinoma
por: Inukai, Yosuke, et al.
Publicado: (2023) -
Pipeline Esophagogastric Varices Secondary to Extrahepatic Portal Vein Obstruction Treated Endoscopically with the Assistance of Transileocolic Obliteration
por: Yokoyama, Shinya, et al.
Publicado: (2022) -
Distinct features of two lipid droplets types in cell nuclei from patients with liver diseases
por: Imai, Norihiro, et al.
Publicado: (2023) -
Patients with low muscle mass have characteristic microbiome with low potential for amino acid synthesis in chronic liver disease
por: Yamamoto, Kenta, et al.
Publicado: (2022) -
Changes in the gut microbiota after hepatitis C virus eradication
por: Honda, Takashi, et al.
Publicado: (2021)